Safety of surgery in patients (pts) with locally recurrent (LR) or metastatic breast cancer (mBC) treated with docetaxel (D) plus bevacizurnab (BV) or placebo (PL) in the AVADO phase III study Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Cortes, J
  • Pivot, X
  • Schneeweiss, A
  • Wilcken, N
  • Ellis, Peter
  • Linderholm, BK
  • Ribelles, N
  • Clemens, M
  • Haslbauer, F
  • Miles, DW

publication date

  • January 15, 2009